Androgen Deprivation Therapy and Risk of SARS-CoV-2 Infection in Men With Prostate Cancer: A University of California Health System Registry Study

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:17 / 18
页数:2
相关论文
共 50 条
  • [1] Androgen deprivation therapy and risk of SARS-CoV-2 infection in men with prostate cancer: A University of California (UC) Health System registry study.
    Kwon, Daniel
    Vashisht, Rohit
    Borno, Hala
    Aggarwal, Rahul Raj
    Small, Eric Jay
    Butte, Atul
    Huang, Franklin W.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [2] Androgen-deprivation therapy and SARS-CoV-2 in men with prostate cancer: findings from the University of California Health System registry
    Kwon, D. H.
    Vashisht, R.
    Borno, H. T.
    Aggarwal, R. R.
    Small, E. J.
    Butte, A. J.
    Huang, F. W.
    ANNALS OF ONCOLOGY, 2021, 32 (05) : 678 - 679
  • [3] Androgen Deprivation Therapy in Men with Prostate Cancer Does Not Affect Risk of Infection with SARS-CoV-2
    Klein, Eric A.
    Li, Jianbo
    Milinovich, Alex
    Schold, Jesse D.
    Sharifi, Nima
    Kattan, Michael W.
    Jehi, Lara
    JOURNAL OF UROLOGY, 2021, 205 (02): : 441 - 443
  • [4] Androgen deprivation and SARS-CoV-2 in men with prostate cancer
    Koskinen, M.
    Carpen, O.
    Honkanen, V.
    Seppanen, M. R. J.
    Miettinen, P. J.
    Tuominen, J. A.
    Raivio, T.
    ANNALS OF ONCOLOGY, 2020, 31 (10) : 1417 - 1418
  • [5] On the relationship between androgen-deprivation therapy for prostate cancer and risk of infection by SARS-CoV-2
    Caffo, O.
    Zagonel, V.
    Baldessari, C.
    Berruti, A.
    Bortolus, R.
    Buti, S.
    Ceresoli, G. L.
    Donini, M.
    Ermacora, P.
    Fornarini, G.
    Fratino, L.
    Masini, C.
    Massari, F.
    Mosca, A.
    Mucciarini, C.
    Procopio, G.
    Tucci, M.
    Verri, E.
    Zucali, P.
    Buttigliero, C.
    ANNALS OF ONCOLOGY, 2020, 31 (10) : 1415 - 1416
  • [6] Androgen Deprivation Therapy in Men with Prostate Cancer Does Not Affect Risk of Infection With SARS-CoV-2. Letter
    MacDonald, Scott
    de Oliveira, Andre Matos
    Wambier, Carlos G.
    JOURNAL OF UROLOGY, 2021, 206 (03): : 784 - 785
  • [7] Impacts of androgen deprivation therapy on the risks and outcomes of SARS-CoV-2 infection in patients with prostate cancer
    Huang, Yuan-Bin
    Li, Wei-Lin
    Sun, Man
    Duan, Xu
    Wang, Yu-Tong
    Zhang, Lu-Xin
    Xin, Zi-Han
    Yun, Zhi-Fei
    Fan, Bo
    Li, Xian-Cheng
    ASIAN JOURNAL OF ANDROLOGY, 2023, 25 (03) : 366 - 374
  • [8] Y Androgen Deprivation Therapy in Men with Prostate Cancer Does Not Affect Risk of Infection with SARS-CoV-2. Reply
    Klein, Eric A.
    JOURNAL OF UROLOGY, 2021, 206 (03): : 785 - 785
  • [9] Susceptibility to SARS-Cov-2 infection and risk for severe COVID-19 in patients with prostate cancer on androgen deprivation therapy
    Gedeborg, Rolf
    Loeb, Stacy
    Styrke, Johan
    Kiiski-Berggren, Ritva
    Garmo, Hans
    Stattin, Par
    INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (11) : 1925 - 1934
  • [10] Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients?
    Dalla Volta, Alberto
    Valcamonico, Francesca
    Zamboni, Stefania
    Ferrari, Vittorio D.
    Grisanti, Salvatore
    Simeone, Claudio
    Berruti, Alfredo
    MINERVA UROLOGICA E NEFROLOGICA, 2020, 72 (06) : 778 - 779